| Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $3 |
| 2021 | $2 |
| 2020 | $0 |
| Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $1 |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | $0 |
| 2022-09-30 | $3 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | $-2 |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OncoCyte (IMDX) | United States | $0.121B | 0.00 |
| GlycoMimetics (CBIO) | United States | $0.010B | 0.00 |
| Brooge Energy (BROGF) | United Kingdom | $0.000B | 0.00 |
| LeddarTech Holdings (LDTCF) | Canada | $0.000B | 0.00 |